Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced an ambitious share repurchase program, with plans to buy back B shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As part of the program, the company has already repurchased 1,926,500 B shares at an average price of DKK 864.79 each, totaling DKK 1.66 billion in transactions. This initiative underscores Novo Nordisk’s commitment to shareholder value and reflects its robust financial strategy.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
